← Human Trials & Peer-Reviewed Studies
Association between vitamin D deficiency and benign paroxysmal positional vertigo (BPPV) incidence and recurrence: a systematic review and meta-analysis.
Plain-language guide to PMID 38653514 (2024): meta-analysis of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 38653514
- Journal
- BMJ open
- Year
- 2024
- Study type
- Meta-Analysis
- Authors
- Wood H et al. (3 authors)
- DOI
- 10.1136/bmjopen-2023-077986
What This Paper Covers, in Plain Language
What It Covers
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a meta-analysis.
The objective of this study is to determine the relationship between serum vitamin D level and the risk of developing benign paroxysmal positional vertigo (BPPV) incidence and recurrence in countries in the Northern Hemisphere.
Why It Was Studied
PubMed, Scopus and Web of Science databases were searched for studies published between January 2000 and February 2023.
Participants located in the Northern Hemisphere aged 18 or over with at least one episode of BPPV, serum 25-hydroxyvitamin D levels measured and reported, no comorbidities or history of vitamin D supplementation.
Who the Included Studies Covered
Inclusion and exclusion criteria and risk of bias were assessed by two independent reviewers using the Newcastle Ottawa Tool for Cohort studies and Risk of Bias Assessment Tool for Nonrandomised Studies checklist for case-control studies.
What Was Measured
Participants located in the Northern Hemisphere aged 18 or over with at least one episode of BPPV, serum 25-hydroxyvitamin D levels measured and reported, no comorbidities or history of vitamin D supplementation.
PubMed files the paper under topics including Benign Paroxysmal Positional Vertigo, Vitamin D Deficiency, Recurrence, Incidence and Vitamin D.
Author keywords: Adult otolaryngology, Audiology, Meta-Analysis and Systematic Review.
What This Means in Plain Language
This is a meta-analysis of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2024 (BMJ open), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.